Fibrosis: types, effects, markers, mechanisms for disease progression, and its relation with oxidative stress, immunity, and inflammation
SA Antar, NA Ashour, ME Marawan… - International Journal of …, 2023 - mdpi.com
Most chronic inflammatory illnesses include fibrosis as a pathogenic characteristic.
Extracellular matrix (ECM) components build up in excess to cause fibrosis or scarring. The …
Extracellular matrix (ECM) components build up in excess to cause fibrosis or scarring. The …
Inflammation: a putative link between phosphate metabolism and cardiovascular disease
J Voelkl, D Egli-Spichtig, I Alesutan… - Clinical Science, 2021 - portlandpress.com
Dietary habits in the western world lead to increasing phosphate intake. Under physiological
conditions, extraosseous precipitation of phosphate with calcium is prevented by a mineral …
conditions, extraosseous precipitation of phosphate with calcium is prevented by a mineral …
Therapeutic targets for heart failure identified using proteomics and Mendelian randomization
Background: Heart failure (HF) is a highly prevalent disorder for which disease mechanisms
are incompletely understood. The discovery of disease-associated proteins with causal …
are incompletely understood. The discovery of disease-associated proteins with causal …
Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox
ZX Wang, ZW Luo, FXZ Li, J Cao, SS Rao… - Nature …, 2022 - nature.com
Adipocyte differentiation of bone marrow mesenchymal stem/stromal cells (BMSCs) instead
of osteoblast formation contributes to age-and menopause-related marrow adiposity and …
of osteoblast formation contributes to age-and menopause-related marrow adiposity and …
FGF23 and phosphate–cardiovascular toxins in CKD
I Vogt, D Haffner, M Leifheit-Nestler - Toxins, 2019 - mdpi.com
Elevated levels of fibroblast growth factor 23 (FGF23) and phosphate are highly associated
with increased cardiovascular disease and mortality in patients suffering from chronic kidney …
with increased cardiovascular disease and mortality in patients suffering from chronic kidney …
The role of fibroblast growth factor 23 in inflammation and anemia
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease
L Ouyang, X Su, W Li, L Tang, M Zhang… - The Journal of …, 2021 - Am Soc Clin Investig
Vascular calcification (VC) predicts cardiovascular morbidity and mortality in chronic kidney
disease (CKD). To date, the underlying mechanisms remain unclear. We detected leukocyte …
disease (CKD). To date, the underlying mechanisms remain unclear. We detected leukocyte …
Osteocytic FGF23 and its kidney function
Osteocytes, which represent up to 95% of adult skeletal cells, are deeply embedded in bone.
These cells exhibit important interactive abilities with other bone cells such as osteoblasts …
These cells exhibit important interactive abilities with other bone cells such as osteoblasts …
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease
Fibroblast growth factor (FGF) 23 is a phosphate-regulating hormone that is elevated in
patients with chronic kidney disease and associated with cardiovascular mortality …
patients with chronic kidney disease and associated with cardiovascular mortality …
The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials
A Zittermann, HK Berthold, S Pilz - European Journal of Clinical …, 2021 - nature.com
The phosphaturic hormone fibroblast growth factor 23 (FGF23) is a risk marker of
cardiovascular and all-cause mortality. We therefore aimed to synthesize the evidence for …
cardiovascular and all-cause mortality. We therefore aimed to synthesize the evidence for …